Trastuzumab
BO30185
Phase 1 small_molecule completed
Quick answer
Trastuzumab for Early Breast Cancer is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Early Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed